portland independent media center  
images audio video
newswire article reporting global


ANC accuses US of using Africans to promote nevirapine AIDS drug

More shocking news of drugs company crimes against humanity
ANC accuses US of using Africans to promote nevirapine AIDS drug

18 Dec 2004

Thabo Mbeki's ruling party of South Africa, the ANC (African National Congress), has attacked top US officials and accused them of using African women and babies as human guinea pigs to promote nevirapine, a controversial AIDS drug.

They have accused US officials of lying.

Doctors and health professionals in Africa fear the use of nevirapine may be halted as a result.

Nevirapine is said to protect thousands of babies in Africa from getting AIDS from their mothers.
US health officials are accused of withholding negative evidence regarding nevirapine from the Bush administration just before President Bush launched a 2002 plan to distribute nevirapine in Africa.

Nevirapine is made by Boehringer Ingelheim.
Boehringer Ingelheim provides key background on nevirapine

Statement issued by Boehringer Ingelheim Pharmaceuticals, Inc., USA

In light of recent interest in the use of Viramune® (nevirapine), Boehringer Ingelheim (BI) provides the following background information on the drug and key events that have been revisited by the media.

Viramune has played a vital role in the fight against HIV/AIDS since its U.S. regulatory approval in 1996. The first drug in its class (non-nucleoside reverse transcriptase inhibitor), Viramune has been an important component in the effort to improve HIV drug therapy.

Research supporting Viramune has helped evolve clinical management standards and has defined the current role of this drug both in chronic combination therapy and in the prevention of mother to child transmission (pMTCT) during childbirth in resource-limited settings.

Viramune for pMTCT in the developing world

The use of Viramune has been shown in clinical studies to reduce HIV transmission rates to infants from infected mothers by 40% or more, by giving a simple regimen of Viramune that includes a single dose to the mother during labor and a single dose to the infant after delivery.1

This regimen has earned the support of the public health and HIV/AIDS treatment communities, who recognize its value as an alternative option in the developing world and understand the clinical research that has clearly defined its utility in this setting.2 In resource-limited settings, single-dose Viramune is often the most feasible treatment to prevent HIV transmission from mother to child.

The 2004 World Health Organization guidelines continue to recommend its use as a practical option in the developing world.3 Through the Viramune Donation Program, BI has expanded global access to this important medication to 122 programs in 57 developing countries.

In 1997, the National Institutes of Health (NIH) requested BI's support for a study (HIVNET 012) to determine what had not yet been clearly defined: whether a simple, inexpensive, single-dose regimen of Viramune could effectively block mother-to-infant HIV transmission.

BI provided support as requested by NIH and supplied the drug for a study in Uganda. Based on the very positive results of this study, BI submitted an NDA supplement to obtain an indication for pMTCT in 2001.

Subsequently, BI conducted a site review of this NIH study in 2002 to assess the site's readiness for an FDA audit. The company provided preliminary findings of this site review to the NIH to signal potential issues requiring follow up.

BI distributed multiple copies of its findings to key study team members at the NIH, the study's contract monitor, and Ugandan and U.S. investigators to validate our preliminary assessment and to encourage prompt correction of observed procedural deficiencies prior to the planned FDA audit.

The FDA audit was cancelled because the Ugandan study site could not correct these procedural deficiencies in the regulatory timeframe of the FDA supplement. Accordingly, BI withdrew its supplemental filing in March 2002.

Following multiple reviews by NIH and the National Institute of Allergies and Infectious Diseases (NIAID), overall study conclusions regarding the safety and efficacy of single-dose Viramune in this setting have remained intact and have contributed to the evidence provided by other studies regarding the role of Viramune in pMTCT.4

Viramune as part of combination therapy for the treatment of HIV/AIDS in the developed world
Viramune as treatment for chronic HIV/AIDS in combination with other HIV (antiretroviral) drugs has been used in more than 600,000 patient years worldwide since its approval in 1996.

As knowledge about HIV infection and its treatment evolves, the understanding of Viramune's role in combination therapy also has increased, and BI continues to educate and support physicians' efforts to identify those patients most likely to benefit from treatment with Viramune.

Treatment with Viramune as part of combination therapy needs to be managed differently than the single-dose regimen administered in the developing world for pMTCT.

Because HIV is a serious and life-threatening disease it requires treatment with potent medicines, all of which can cause serious adverse events.

The most clinically important adverse events associated with Viramune are rash and liver-related events, which in rare cases may be severe and life threatening.

The greatest risk of these events occurs within the first six weeks of therapy. Events are usually managed adequately if careful monitoring takes place throughout the course of therapy.
BI's commitment to the fight against HIV/AIDS
BI is a steadfast partner to professionals, patients, government and non-governmental organizations (NGOs) in the fight against HIV/AIDS.

With our partners we are working toward a goal of ensuring that the next generation of infants in the developing world are born HIV-free. It is important that media reports preserve accuracy to ensure that people in AIDS-ravaged countries are not unnecessarily discouraged from continuing to use Viramune and other treatments to prevent the transmission of HIV during childbirth.

Contact for queries from European journalists:
Boehringer Ingelheim GmbH
Judith von Gordon
55216 Ingelheim am Rhein
Phone: +49/6132/77 35 82
Fax: +49/6132/77 66 01


1 Guay LA. Musoke P. Fleming T. Bagenda D. Allen M. Nakabiito C. Sherman J. Bakaki P. Ducar C. Deseyve M. Emel L. Mirochnick M. Fowler MG. Mofenson L. Miotti P. Dransfield K. Bray D. Mmiro F. Jackson JB. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.[see comment]. [Clinical Trial. Clinical Trial, Phase III. Journal Article. Randomized Controlled Trial] Lancet. 354(9181):795-802, 1999 Sep 4.
Jackson JB. Musoke P. Fleming T. Guay LA. Bagenda D. Allen M. Nakabiito C. Sherman J. Bakaki P. Owor M. Ducar C. Deseyve M. Mwatha A. Emel L. Duefield C. Mirochnick M. Fowler MG. Mofenson L. Miotti P. Gigliotti M. Bray D. Mmiro F. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. [Clinical Trial. Journal Article. Randomized Controlled Trial] Lancet. 362(9387):859-68, 2003 Sep 13
Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V, and the Perinatal HIV Prevention Trial Group (PHPT). (LB-40) A Randomized, Double-Blind Trial Assessing the Efficacy of Single-Dose Perinatal Nevirapine Added to a Standard Zidovudine Regimen for the Prevention of Mother-to-Child Transmission of HIV-1 in Thailand. Presented at 11th Conference on Retroviruses and Opportunistic Infections. 8-11 Feb 04, San Francisco, CA.
SAINT study: Moodley D, Moodly J, Coodavia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, for the South African Intrapartum Nevirapine Trial (SAINT) Investigators. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. Journal of Infectious Diseases 2003;187:725-735.

2 WHO: Antiretroviral drugs for treating pregnant women and prevention HIV infection in infants: guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. World Health Organization; July 2004.

3 Elizabeth Glaser Pediatric AIDS Foundation On Issue Of Prevention Of Mother-To-Child Transmission Of HIV/AIDS And Single-Dose Nevirapine [statement]. Elizabeth Glaser Pediatric AIDS Foundation; December 14, 2004.

4 NIAID & NIH: The HIVNET 012 Study and the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV [press release]; December 14, 2004.

homepage: homepage: http://www.dissidentaction.com

Military/Pharmacuetical Warfare 18.Dec.2004 22:48


People in the so called "aids-ravaged countries" NECESSARILY need to be warned about these deadly drug/poisons mis-named "medicines". Thabo Mbecki is a courageous hero whose intelligent voice of sanity should be praised instead of villified. HIV=Aids is chemical warfare very cleverly disguised as humanitarian concern much like the brutal invasion and occupation of Iraq is disguised as bringing democracy and liberation to the people of Iraq.
The theory that HIV causes aids has never been proven. I cannot understand why so many people especially so-called progressives, intellectuals and "experts" do not question this. Instead it appears that doctors, scientists and other medical experts are regarded as gods and to question them is heresy. I say remove the shackles and let us expose this scam before many more people have to suffer and die. This is just another method of genocide. For more information check out the following websites and decide for yourself.
www. aliveandwell.org

The Truth About AIDS 19.Dec.2004 08:36


I recommend the book: Emerging Viruses: AIDS & Ebola Nature, Accident or Intentional?

This is a well-researched and well written book by Leonard G. Horowitz

For more information, please contact:
Tetrahedron, Inc.
Suite 147,
206 North 4th Avenue
Sandpoint, Idaho 83864
Fax: 208-265-2775

E-mail:  tetra@tetrahedron.org
URL:  http://www.tetrahedron.org

I agree 19.Dec.2004 14:47

Paul King

All that is happening in Africa is old epidemic diseases are being renamed "AIDS' in order that drugs companies can make vast fortunes selling their toxic 'meds'.

The increased death from their side effects are then used to further promote the myth.

Smart business, if you are devoid of any morals.


AIDS and the left 19.Dec.2004 18:17

wily retrovirus

It's funny how the left like to imagine themselves as highly educated and thoughtful on a great number of issues. They're as dumb as a box of rocks when it comes to "AIDS". Wake up, lefties! Twenty years of AIDS, over $100 billion spent, no vaccine. What's going on here?

Wake up folks!

MYTH 19.Dec.2004 18:32

David Lane


The multi-billion dollar AIDS/HIV fraud is based on two fabrications: that AIDS is a single disease and that it is caused by the HI virus or the "HIV virus" as some medical/media masterminds call it - perhaps they think the V in HIV stands for volcano.

In Japan "AIDS" is virtually unknown : yet, in random tests, 25% of people were found to be "HIV-positive".
HIV-positive response means nothing of any relevance to health: it can be triggered by vaccination, malnutrition, M.S., measles, influenza,
papilloma virus wart, Epstein Barr virus, leprosy, glandular fever, hepatitis, syphillis ... : over sixty different conditions.

Dr Robert E. Willner, inoculated himself with the blood of Pedro Tocino, a HIV-positive haemophiliac, on live Spanish television: an event which was not picked up the pharma-beholden British or US media.

The great HIV/AIDS lie was created by Robert Gallo who was found guilty of "scientific misconduct". "...instead of trying to prove his insane theories about AIDS to his peers...he went public. Then, with the help of
Margaret Heckler, former head of Health and Human Services, who was under great political pressure to come up with an answer to AIDS, the infamous
world press announcement of the discovery of the so-called AIDS virus came about.

This great fraud is now responsible for the deaths of hundreds of thousands... It was no accident that Gallo just happened to patent the test for HIV the day after the announcement...Gallo is now a multi-millionaire because of AIDS and his fraudulent AIDS test." Dr.

By grouping together 25-plus different diseases and other allied factors -
pneumonia, herpes, candidiasis, salmonella, various cancers, infections, vaccine and antibiotic damage, amyl nitrate damage, malnutrition etc.and,
particularly in Africa, TB, malaria, dysentery leprosy and "slim disease" - and calling the whole thing an "AIDS epidemic", a multi-billion dollar/pound "AIDS research and treatment" racket has been created.

The mythical "HIV-induced AIDS plague" in the Third World generates huge sums of cash from Western relief organisations whilst smokescreening the
vaccine/drug boys, responsible for the carnage.

Every death of someone "HIV-positive" is recorded as an "AIDS death".

Periodically, the BBC/ITV/Press visit
Africa/Yugoslavia/Russia etc to
report on the "HIV/AIDS victims" and how they cannot afford the "life-saving AZT." Glaxo Wellcome's lethal drug, AZT, in combination with the diagnosis of
HIV-positive and the prediction, stated or implied, that - "You will die of AIDS" is one of the great pieces of Medical Black Magic - Voodoo Medicine at its most impressive: people have committed suicide on the
basis of the ludicrous diagnosis.

Pregnant women who are HIV-positive have been told to stop breast-feeding, dosed with AZT, have had abortions or have been sterilised. HIV-positive
babies who become ill -from vaccination or whatever - are automatically diagnosed as "suffering from AIDS".
"Considering that there is little scientific proof of the exact linkage of HIV and AIDS, is it ethical to prescribe AZT, a toxic chain terminator of DNA...to 150,000 Americans - among them pregnant women and newborn babies..? Rep.G Gutknecht US House of Representatives.

New Labour "Health" have now announced that all pregnant women in the UK will be "offered" a HIV test. Those who fall for the scam and who are diagnosed as "HIV positive" will be given the chance to have themselves and their unborn child permanently damaged by AZT etc. Pregnancy, itself, can cause a positive diagnosis.

AZT began as a "cancer drug" but was withdrawn for being too toxic: like being thrown out of the Gestapo for cruelty. Its effects include - cancer, hepatitis, dementia, seizures, anxiety, impotence, leukopaenia, , severe
nausea, ataxia, etc. and the termination of DNA synthesis. i.e. AIDS/death by prescription. AZT eventually kills all those who continue to take it.

"WARNING : Retrovir (AZT)...has been associated with symptomatic myopathy, similar to that produced by Human Immunodeficiency Virus..." Glaxo
Wellcome literature!

None of which stops the medical trade from pushing it on every trusting sap who is not ill to start with but is labelled with the "HIV-positive" nonsense and then destroyed by AZT; with "AIDS" getting the blame - and
more billions pouring in for the drug boys, vivisectors, animal breeders and the rest. The latest stunt is to give a "cocktail" of drugs - including AZT, of course, and at £12,000 per head, per year - to all homosexual men who are "HIV-positive".

A particularly good scam is to haul into court someone "guilty of deliberately infecting the victim with the 'HIV-Virus which causes AIDS' " which then develops into "full-blown AIDS" - no mention of vaccine,
antibiotic damage etc or full-blown AZT. Over 2000 - and rising, of the world's scientists are now disputing the HIV hoax, their efforts being continually suppressed by the AIDS establishment, the pharmaceutical/vivisection syndicate and their political and media lackeys